One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
https://doi.org/10.1001/jama.2022.21250
Copy DOI
Export
Save
Share
Cite Journal: JAMA |  Publication Date: Nov 10, 2022 |
 Citations: 1 |
Affiliation: University of California, Berkeley
This Viewpoint discusses the market for generic drugs and an innovation surcharge that would be awarded to public entities, such as the National Institutes of Health, and its newly formed Advanced Research Projects Agency for Health, to fund research for the repurposing of generic drugs.
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
